Validity of multiplex-based assays for cytokine measurements in serum and plasma from "non-diseased" subjects: Comparison with ELISA
Validity of multiplex-based assays for cytokine measurements in serum and plasma from "non-diseased" subjects: Comparison with ELISA
复制标题
DOI:
10.1016/j.jim.2009.09.001
复制
发表时间:
2009-10-31
影响因子:
2.2
通讯作者:
Rinaldi, Sabina
中科院分区:
文献类型:
--
作者:
Dossus, Laure;Becker, Susen;Rinaldi, Sabina
Multiplex-based immunoassays (MIA) allow the simultaneous measurement of different cytokines in small sample Volumes, but their applicability in samples from "healthy" subjects, as those participating in large-scale epidemiological studies is not well known. We compared measurements of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), interleukin-1 receptor antagonist (IL-1Ra), C-reactive protein (CRP) and soluble CD40L (sCD40L) obtained by MIA with those obtained by enzyme-linked immunosorbent assays (ELISA) in serum and plasma samples from 36 "healthy" subjects. We observed good correlations between measurements obtained by MIA and ELISA for IL-1Ra, CRP and sCD40L (r > 0.80) but poor correlations for IL-6, TNF-alpha and IL-1 beta (r < 0.40). When comparing MIA plasma and serum measurements, very high correlations were obtained for CRP (r = 0.98) and fairly good correlations for IL-1Ra (r = 0.60). In conclusion, multiplex-based assays can give an accurate estimate of the relative risk in large-scale epidemiological studies but only for cytokines that are present in relatively large concentrations (ng/mL). (C) 2009 Elsevier B.V. All rights reserved.